IB
INTELLIGENT BIO SOLUTIONS INC.
SEC filingOther Health Care · New York, NY
Amount raised$5Msold at filing
Total offering$5M
Investors in the raise1count reported to the SEC
FiledSep 14, 2026first sale Aug 31, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Harry SimeonidisExecutive Officer
Steven BoyagesDirector
Jonathan HurdDirector
Nicola FraserDirector
Spiro SakirisExecutive Officer
Jason IsenbergDirector
Executive officers, directors and promoters as listed on the Form D.